Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2025-09-15 00:00:00 ET · period of report 2025-09-11 · accession 0001683168-25-006957 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-15 | 2025-09-11 | PHIO | Ferrara Robert L | Dir | A - Grant | $0.00 | +23.0K | 38.7K | +147% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.0001 par value | 2025-09-11 | A | A | 23,000 | $0.00 | 38,666 | D | — | — | (F1) Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant. (F2) Includes shares of common stock underlying unvested restricted stock units. (F3) The number of reported securities has been adjusted to reflect prior reverse stock splits. |